A leader of our Gamma Knife Center shares how this stereotactic radiosurgery technology has progressed over recent decades and where it may be headed next.
Combining stereotactic radiosurgery with an epidermal growth factor receptor-tyrosine kinase inhibitor may benefit patients with brain metastases from NSCLC but further study is needed to change standard of care.
New study evaluates the safety and efficacy of preoperative stereotactic radiosurgery.
Treatment goals in this setting are to extend survival, prevent neurological dysfunction and improve quality of life. Advances is surgical safety, stereotactic radiosurgery and systemic therapies have yielded mounting progress.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
From fractionated and volume-based staged radiosurgery strategies to use in combination with targeted immunotherapy, centers like Cleveland Clinic are finding new ways to make the most of this targeted stereotactic radiosurgery modality.
A prospective pilot study conducted in 16 patients with brain metastases found that 18F fluciclovine PET CT demonstrated promising utility in distinguishing radiation necrosis from tumor progression among patients treated with stereotactic radiosurgery.
If findings continue to echo results to date, preoperative higher-dose stereotactic radiosurgery could represent a new standard of care for patients with large brain metastases.
Stereotactic radiosurgery, used most often for adult brain tumors, also has promising benefits for pediatric tumors. Dr. Erin Murphy shares results of her study in pilocytic astrocytoma.
More and more of our patients with brain metastases are undergoing stereotactic radiosurgery. Recent outcomes data show it’s paying off in terms of survival and functional performance.
Another large retrospective analysis raises questions around the ARUBA trial’s findings on surgery vs. watch-and-wait for unruptured brain arteriovenous malformations.